α-Lipoic acid mitigates age-related macular degeneration via ferroptosis: integrative multi-omics and network pharmacology

BackgroundAge-related macular degeneration (AMD) is a leading cause of irreversible vision loss among the elderly. α-Lipoic acid (ALA), a naturally occurring antioxidant and iron-chelator, has shown potential in modulating ferroptosis, but its mechanism in AMD remains unclear.MethodsNetwork pharmaco...

Full description

Saved in:
Bibliographic Details
Main Authors: Yaqiong Zhang, Yuanyuan Chen, Chenglin Sun, Fang Li, Yin Shen
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1626907/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849420795041808384
author Yaqiong Zhang
Yaqiong Zhang
Yuanyuan Chen
Chenglin Sun
Fang Li
Yin Shen
Yin Shen
author_facet Yaqiong Zhang
Yaqiong Zhang
Yuanyuan Chen
Chenglin Sun
Fang Li
Yin Shen
Yin Shen
author_sort Yaqiong Zhang
collection DOAJ
description BackgroundAge-related macular degeneration (AMD) is a leading cause of irreversible vision loss among the elderly. α-Lipoic acid (ALA), a naturally occurring antioxidant and iron-chelator, has shown potential in modulating ferroptosis, but its mechanism in AMD remains unclear.MethodsNetwork pharmacology, transcriptomic profiling, and machine learning were used to identify potential molecular targets of ALA in AMD. Core genes were identified through interaction network construction, functional enrichment analysis, and machine learning-based screening. Molecular docking and molecular dynamics simulations were performed to assess the binding affinity and stability between ALA and its predicted targets. In vivo validation was conducted using a sodium iodate (SI)-induced AMD mouse model, with retinal structure, function, oxidative stress, and gene expression evaluated through behavioral tests, histological staining, and qRT-PCR.ResultsWe identified six ferroptosis-related core targets (AHCY, DHODH, MAPK1, MAPK8, NOS2, and HMOX1) of ALA implicated in AMD. Molecular docking revealed strong binding affinities between ALA and these six targets, with dynamic simulations confirming stable interactions, particularly with HMOX1 and MAPK1. In the SI-induced AMD mouse model, ALA significantly preserved retinal structure, maintained visual function, and reduced oxidative stress and iron accumulation. qRT-PCR confirmed that ALA exerted differential effects on the expression of the six genes, demonstrating a context-dependent regulatory mechanism.ConclusionThis study provides multi-level evidence that ALA protects against AMD by modulating ferroptosis-related pathways and restoring retinal structural integrity and functions. These findings warrant further investigation into the therapeutic potential of ALA in AMD.
format Article
id doaj-art-536d7643a15e487eaa9cec0eff53247b
institution Kabale University
issn 1663-9812
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-536d7643a15e487eaa9cec0eff53247b2025-08-20T03:31:38ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-07-011610.3389/fphar.2025.16269071626907α-Lipoic acid mitigates age-related macular degeneration via ferroptosis: integrative multi-omics and network pharmacologyYaqiong Zhang0Yaqiong Zhang1Yuanyuan Chen2Chenglin Sun3Fang Li4Yin Shen5Yin Shen6Eye Center, Renmin Hospital of Wuhan University, Wuhan, Hubei, ChinaXiangyang No.1 People’s Hospital, Hubei University of Medicine, Xiangyang, Hubei, ChinaEye Center, Renmin Hospital of Wuhan University, Wuhan, Hubei, ChinaXiangyang No.1 People’s Hospital, Hubei University of Medicine, Xiangyang, Hubei, ChinaDepartment of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, ChinaEye Center, Renmin Hospital of Wuhan University, Wuhan, Hubei, ChinaFrontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, Hubei, ChinaBackgroundAge-related macular degeneration (AMD) is a leading cause of irreversible vision loss among the elderly. α-Lipoic acid (ALA), a naturally occurring antioxidant and iron-chelator, has shown potential in modulating ferroptosis, but its mechanism in AMD remains unclear.MethodsNetwork pharmacology, transcriptomic profiling, and machine learning were used to identify potential molecular targets of ALA in AMD. Core genes were identified through interaction network construction, functional enrichment analysis, and machine learning-based screening. Molecular docking and molecular dynamics simulations were performed to assess the binding affinity and stability between ALA and its predicted targets. In vivo validation was conducted using a sodium iodate (SI)-induced AMD mouse model, with retinal structure, function, oxidative stress, and gene expression evaluated through behavioral tests, histological staining, and qRT-PCR.ResultsWe identified six ferroptosis-related core targets (AHCY, DHODH, MAPK1, MAPK8, NOS2, and HMOX1) of ALA implicated in AMD. Molecular docking revealed strong binding affinities between ALA and these six targets, with dynamic simulations confirming stable interactions, particularly with HMOX1 and MAPK1. In the SI-induced AMD mouse model, ALA significantly preserved retinal structure, maintained visual function, and reduced oxidative stress and iron accumulation. qRT-PCR confirmed that ALA exerted differential effects on the expression of the six genes, demonstrating a context-dependent regulatory mechanism.ConclusionThis study provides multi-level evidence that ALA protects against AMD by modulating ferroptosis-related pathways and restoring retinal structural integrity and functions. These findings warrant further investigation into the therapeutic potential of ALA in AMD.https://www.frontiersin.org/articles/10.3389/fphar.2025.1626907/fullage-related macular degeneration (AMD)ferroptosisα-Lipoic acid (ALA)network pharmacologymulti-omics
spellingShingle Yaqiong Zhang
Yaqiong Zhang
Yuanyuan Chen
Chenglin Sun
Fang Li
Yin Shen
Yin Shen
α-Lipoic acid mitigates age-related macular degeneration via ferroptosis: integrative multi-omics and network pharmacology
Frontiers in Pharmacology
age-related macular degeneration (AMD)
ferroptosis
α-Lipoic acid (ALA)
network pharmacology
multi-omics
title α-Lipoic acid mitigates age-related macular degeneration via ferroptosis: integrative multi-omics and network pharmacology
title_full α-Lipoic acid mitigates age-related macular degeneration via ferroptosis: integrative multi-omics and network pharmacology
title_fullStr α-Lipoic acid mitigates age-related macular degeneration via ferroptosis: integrative multi-omics and network pharmacology
title_full_unstemmed α-Lipoic acid mitigates age-related macular degeneration via ferroptosis: integrative multi-omics and network pharmacology
title_short α-Lipoic acid mitigates age-related macular degeneration via ferroptosis: integrative multi-omics and network pharmacology
title_sort α lipoic acid mitigates age related macular degeneration via ferroptosis integrative multi omics and network pharmacology
topic age-related macular degeneration (AMD)
ferroptosis
α-Lipoic acid (ALA)
network pharmacology
multi-omics
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1626907/full
work_keys_str_mv AT yaqiongzhang alipoicacidmitigatesagerelatedmaculardegenerationviaferroptosisintegrativemultiomicsandnetworkpharmacology
AT yaqiongzhang alipoicacidmitigatesagerelatedmaculardegenerationviaferroptosisintegrativemultiomicsandnetworkpharmacology
AT yuanyuanchen alipoicacidmitigatesagerelatedmaculardegenerationviaferroptosisintegrativemultiomicsandnetworkpharmacology
AT chenglinsun alipoicacidmitigatesagerelatedmaculardegenerationviaferroptosisintegrativemultiomicsandnetworkpharmacology
AT fangli alipoicacidmitigatesagerelatedmaculardegenerationviaferroptosisintegrativemultiomicsandnetworkpharmacology
AT yinshen alipoicacidmitigatesagerelatedmaculardegenerationviaferroptosisintegrativemultiomicsandnetworkpharmacology
AT yinshen alipoicacidmitigatesagerelatedmaculardegenerationviaferroptosisintegrativemultiomicsandnetworkpharmacology